Back

Non-invasive predictors of LV biopsy-obtained creatine kinase activity in patients with non-failing and failing myocardial hypertrophy

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiac hypertrophy Metabolism ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mark Andrew Peterzan

St George's Hospital (London), London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
Glutamine-fructose-6-phosphate amidotransferase 2 mediates isoproterenol-induced cardiac hypertrophy by increasing Akt O-GlcNAcylation through hexosamine biosynthesis pathway
Doctor A. Ishikita (Fukuoka, JP)
Abstract
Presentation thumbnail
Epigenetic modifications via histone acetylation by p300 are changed during the transition from cardiac hypertrophy to heart failure
Mr Y. Sunagawa (Shizuoka, JP)
Abstract
Presentation thumbnail
Inhibition of GATA4 dimerization suppress hypertrophic responses
Mr S. Shimizu (Shizuoka, JP)
Abstract
Presentation thumbnail
Adverse left ventricular remodeling in descending thoracic vs ascending aorta banding in novel porcin model. cMRI study
Doctor S. Popevska (Leuven, BE)
Abstract Slides
Presentation thumbnail
The genetic background of the disease in a group of patients with severe course of hypertrophic cardiomyopathy.
Doctor M. Klopotowski (Warsaw, PL)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Cardiac hypertrophy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Basic science
thumbnail
Congress Presentation
Myocardial energetics: what can we learn for future therapy
thumbnail
Congress Presentation
Proteomics-based computational modelling of myocardial metabolism for personalized phenotyping and outcome prediction in advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources